Back to Research Hub
Caris Life Sciences, Inc.
CAI
$16.99-0.88 (-4.92%)
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally.
StreetsValue research for Caris Life Sciences, Inc. (CAI)
Members get the full report for Caris Life Sciences, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.